MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 

2016 International Congress

June 19-23, 2016. Berlin, Germany.

View by Title View Sessions
View by Date

Thursday, June 23, 2016

12:00pm-1:30pm
A crossover study of pretarsal and preseptal injections of botulinum toxin type A (BTX-A) in the treatment of hemifacial spasm and blepharospasm

A. Choolam, K. Kulkantrakorn, P. Lolekha (Pathumthani, Thailand)

Clinical trials and therapy in movement disorders  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
A double blind investigation of efficacy and safety of incobotulinumtoxinA in Parkinson’s disease tremor- A customized injection approach

S.O. Mittal, R. Rostami, D.G. Machado, D. Richardson, B. Jabbari (Cleveland, OH, USA)

Parkinsons's Disease: Clinical Trials I
12:00pm-1:30pm
A double-blind randomized controlled trial of cognitive training for freezing of gait in Parkinson’s disease

C.C. Walton, L. Mowszowski, J.M. Shine, M. Gilat, J.M. Hall, C. O'Callaghan, A.J. Muller, M. Georiades, J.Y.Y. Szeto, K.A. Ehgoetz Martens, S.L. Naismith, S.J.G. Lewis (Sydney, Australia)

Clinical trials and therapy in movement disorders  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
A dynamic causal model of the superior colliculus: Inhibitory activity increases with the temporal discrimination threshold

B. Quinlivan, R. Moran, E. McGovern, S. Narasimham, I. Beiser, L. Williams, O. Killian, R. Beck, S. O'Riordan, J.S. Butler, M. Hutchinson, R.B. Reilly (Dublin, Ireland)

Dystonia  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
A functional magnetic imaging study of the response in the superior colliculus to looming stimuli in cervical dystonia patients and their relatives

E.M. Mc Govern, S. Narasimham, O. Killian, I. Beiser, L. Williams, B. Quinlivan, J.S. Butler, S. O'Riordan, R.B. Reilly, M. Hutchinson (Dublin, Ireland)

Dystonia  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
A healthy volunteer phase 1 study of RE-024, a potential phosphopantothenate replacement therapy for patients with pantothenate kinase-associated neurodegeneration (PKAN)

R.D. Marshall, A. Harring-Abbott, K. Lucey, K. Leach, M. Beconi, J. Hunt, H. Plotkin (San Diego, CA, USA)

Parkinson's Disease: Clinical Trials II and Non-PD Clinical Trials
12:00pm-1:30pm
A heterozygous splicing mutation c.823-10G>T at the intron9/exon 10 of the MAPT gene in an Irish family with FTDP- 17

E.M. Fallon, D.A. Olszewska, C. McGuigan, I. Delon, F. Brett, B. Lawlor, M. Hutchinson, M. Hutton, T. Lynch (Dublin, Ireland)

Other  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
A multi-centre European comparative survey of advanced therapies (infusion and deep brain stimulation) in Parkinson’s disease

A.M. Rizos, P. Martinez-Martin, P. Reddy, M. Silverdale, K. Ashkan, A. Antonini, D. Calandrella, P. Odin, T. Henriksen, N. Bryndum, A. Glad, M.G. Kramberger, Z. Pirtošek, M. Trošt, T. van Laar, R. Katzenschlager, H.S. Dafsari, L. Timmermann, A. Storch, H. Reichmann, K. Ray Chaudhuri, On behalf of EUROPAR, The IPMDS Non-Motor PD Study Group (London, United Kingdom)

Parkinsons's Disease: Clinical Trials I
12:00pm-1:30pm
A national case study of virtual care visits for Parkinson’s disease (RACE-PD): Interim assessment of participant and investigator experiences

R. Korn, H.T. Keenan, T. Felong, S. Goldenthal, S. Kanchana, H. Schwarz, S. Sharma, K. Andrzejewski, E.A. Stevenson, R. Barbano, G. Kang, K. Rizer, A. Shukla, M.J. Dodge, C. Tanner, M. Katz, R. Rodriguez, N. Galifianakis, W. Zhu (Rochester, NY, USA)

Parkinson's disease: Clinical trials, pharmacology and treatment  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
A new test for the measuring hand functions in Parkinson’s disease: Psychometric evaluation of the squares test

E. Goz, F. Soke, A. Genc, B. Donmez Colakoglu, P. Keskinoglu (Izmir, Turkey)

Other  ·  Exhibit Hall located in Hall B, Level 2